Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma
Clinical trial NCT00570180 · COMPLETED
Trial details
- NCT number
- NCT00570180
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-25
- Primary completion
- 2015-09-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.